Alcoholic energy drink comes under fire in D.C. Sep 13, 2008
The lawsuit claims Sparks products should not be sold in the city because they violate the D.C. Food and Drug Law that prohibits adulterated food products in D.C.. Miller will be served and have up to 30 days to file a response. (Washington Business Journal, DC)
Berkeley Heartlab, Inc. Aug 26, 2008
Except for his four years with the FDA, he has been with the firm his entire career and has taught a course on food and drug law at Harvard Law School. He also has published 175 book chapters and articles on food and drug law and on health policy and has represented national trade associations for the food, prescription drug, nonprescription drug, dietary supplement and cosmetic industries. (San Francisco Business Times, CA)
Peter Barton Hutt Aug 26, 2008
Celera names food and drug law specialist to board - East Bay Business Times ... Celera names food and drug law specialist to board ... Hutt is a senior counsel with the Washington, D.C., law firm , specializing in food and drug law. (East Bay Business Times, CA)
SCALIA CRITICIZES NEWS MEDIA... Mar 28, 2008
Scalia spoke to a friendly and enthusiastic audience from the Food and Drug Law Institute, an organization of attorneys from industry and government specializing in food and drug regulatory law. Copyright 2008 The Associated Press. (The Drudge Report)
Abigail Alliance Will Appeal D.C. Circuit Court Decision Aug 23, 2007
Ballenger, a partner at Latham ns, in Washington, D.C., told attendees at an audio conference sponsored by the Food and Drug Law Institute (FDLI), that, in November, the Abigail Alliance would appeal the ruling by the D.C. Circuit Court of Appeals earlier this month that terminally ill patients did not have a constitutional right to drugs still undergoing review by FDA. "This case is important not just for patients but for policy affecting the entire health care system in the United States,"... (PR Newswire)
Keryx Biopharmaceuticals Names Beth F. Levine as Senior Vice President, General Counsel & Chief Compliance Officer Apr 26, 2007
Ms. Levine joins Keryx with over 15 years of legal experience, focusing primarily on food and drug law, corporate compliance, commercial litigation, licensing and other corporate transactional matters in the pharmaceutical and consumer products industries. Ms. Levine joins Keryx from Pfizer Inc., where she served in various positions in the Legal Division between 1994 and 2007. (PR Newswire)
Desperate cancer patients put hopes on expanded trials Mar 11, 2007
"FDA doesn't want to be liable. The physician doesn't want to be liable. And pharmaceutical companies or device manufacturers don't want to be liable," says Michael Levin-Epstein, editor-in-chief of the Food and Drug Law Institute, a non-profit group funded by the food and drug industry. "Even if these patients are terminally ill, it's possible you could be making them worse," Levin-Epstein says. (USA Today)
